Talc in the news

January 30, 2026 - Attributable to Erik Haas, Worldwide Vice President of Litigation, Johnson & Johnson: “We applaud the trial court for its clear and decisive ruling rejecting the baseless medical monitoring claim. Plaintiff lawyers once again tried to manufacture a frivolous theory of liability, and the Court correctly refused to endorse it. This decision reinforces that meritless pleadings designed to pressure defendants into coercive settlements have no place in our courts.”

January 29, 2026 – Attributable to Erik Haas, Worldwide Vice President of Litigation, Johnson & Johnson:   “The Judge correctly rejected as wholly meritless claims contrived by the plaintiff lawyers in a failed effort to convert a proper divestiture into a fraudulent conveyance.”

Special Master erroneously allowed certain other plaintiffs’ expert opinions - reiterating the same flawed reasoning from her 2020 decision, disregarding changes to the Federal Rules of Evidence Company will promptly appeal to the District Court the erroneous aspects of the recommendation, which has no legal import until that appeal is resolved Recommendation only reinforces the Company’s overall litigation strategy

Company has prevailed in 16 of 17 ovarian cases tried in the last 11 years Company will reverse approximately $7 billion from amounts previously reserved for the bankruptcy resolution